261 related articles for article (PubMed ID: 36060450)
1. Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?
Leopold Z; Passarelli R; Mikhail M; Tabakin A; Chua K; Ennis RD; Nosher J; Singer EA
J Kidney Cancer VHL; 2022; 9(3):5-23. PubMed ID: 36060450
[TBL] [Abstract][Full Text] [Related]
2. Thermal ablation of the small renal mass: a critical analysis of current literature.
Mershon JP; Tuong MN; Schenkman NS
Minerva Urol Nefrol; 2020 Apr; 72(2):123-134. PubMed ID: 31833721
[TBL] [Abstract][Full Text] [Related]
3. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
5. Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.
Young S; Golzarian J; Anderson JK
Semin Intervent Radiol; 2019 Dec; 36(5):367-373. PubMed ID: 31798209
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Image-guided Thermal Ablation for Renal Cell Carcinoma.
Fujimori M; Yamanaka T; Sugino Y; Matsushita N; Sakuma H
Interv Radiol (Higashimatsuyama); 2020 Jun; 5(2):32-42. PubMed ID: 36284654
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ablation of the small renal mass-techniques and outcomes.
Gunn AJ; Gervais DA
Semin Intervent Radiol; 2014 Mar; 31(1):33-41. PubMed ID: 24596438
[TBL] [Abstract][Full Text] [Related]
8. Renal Cell Carcinoma: Alternative Nephron-Sparing Treatment Options for Small Renal Masses, a Systematic Review.
Prins FM; Kerkmeijer LGW; Pronk AA; Vonken EPA; Meijer RP; Bex A; Barendrecht MM
J Endourol; 2017 Oct; 31(10):963-975. PubMed ID: 28741377
[TBL] [Abstract][Full Text] [Related]
9. Renal ablation update.
Khiatani V; Dixon RG
Semin Intervent Radiol; 2014 Jun; 31(2):157-66. PubMed ID: 25049445
[TBL] [Abstract][Full Text] [Related]
10. Ablation of Small Renal Masses.
Abdelsalam ME; Ahrar K
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100674. PubMed ID: 32591194
[TBL] [Abstract][Full Text] [Related]
11. Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.
Shakeri S; Raman SS
Semin Intervent Radiol; 2019 Aug; 36(3):183-193. PubMed ID: 31435126
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
Shakeri S; Raman SS
Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
[TBL] [Abstract][Full Text] [Related]
14. Renal ablation: current management strategies and controversies.
Zhong J; Wah TM
Chin Clin Oncol; 2019 Dec; 8(6):63. PubMed ID: 31968983
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Management of Localized and Locally Advanced Renal Cell Carcinoma: A Narrative Review.
Dhanji S; Wang L; Liu F; Meagher MF; Saidian A; Derweesh IH
Res Rep Urol; 2023; 15():99-108. PubMed ID: 36879830
[TBL] [Abstract][Full Text] [Related]
16. [Small renal cell carcinoma-active surveillance and ablation].
Wendler JJ; Damm R; Liehr UB; Brunner T; Pech M; Schostak M
Urologe A; 2018 Jun; 57(6):731-743. PubMed ID: 29796702
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
18. Thermal ablation in renal cell carcinoma management: a comprehensive review.
Wagstaff P; Ingels A; Zondervan P; de la Rosette JJ; Laguna MP
Curr Opin Urol; 2014 Sep; 24(5):474-82. PubMed ID: 25051022
[TBL] [Abstract][Full Text] [Related]
19. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
[TBL] [Abstract][Full Text] [Related]
20. Update on ablative therapies of renal tumors.
D'Andrea D; Shariat SF; Klatte T
Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
